Welcome to the e-CCO Library!

N17: Azathioprine - Is it really a dirty drug? IBD nurse's experience at Our Lady of Lourdes Hospital
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Anderson, E.(1)*;McMahon, S.(2);
Created: Friday, 14 July 2023, 10:43 AM
N17: Co Design of young person’s IBD clinic for 16-24 year olds
Year: 2022
Source: ECCO'22
Authors: Hamzawi, M.(1);Brannick, S.(2);Hickey, Y.(2);Cullen, G.(2);Sheridan, J.(2);
Created: Friday, 11 February 2022, 3:52 PM
N17: Frequency of infliximab-induced skin lesions and their impact on quality of life in inflammatory bowel disease patients treated with infliximab
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Bobnar Sekulic*1, T. Polanc1, U. Koren2, T. Kurent1, N. Smrekar1, J. Hanžel1, D. Drobne1, G. Novak1

Created: Friday, 22 February 2019, 9:41 AM
N17: The Perceptions and Experiences of People Living with Inflammatory Bowel Disease of Nursing Care A Qualitative Evidence Synthesis
Year: 2021
Source: ECCO'21 Virtual
Authors: Conmy, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
N18 Facilitating involvement of patients from ethnic minority groups in research: experiences of offering patients a choice of interviewer
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. MUKHERJEE, B. Beresford

Created: Thursday, 30 January 2020, 10:12 AM
N18: Exploring the experiences of UK-dwelling Bangladeshi native language-speaking patients with Inflammatory Bowel Disease: preliminary findings from a qualitative study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ahmed, S.(1);Singh, H.(2,3);Newton, P.(1)*;Ojo, O.(1);Dibley, L.(1);
Created: Friday, 14 July 2023, 10:43 AM
N18: Introduction of inflammatory bowel disease specialized dietitian and nutritional status in a multidisciplinary IBD team
Year: 2022
Source: ECCO'22
Authors: Hoekx, S.(1);Vanderstappen, J.(1);Wellens, J.(1);Verstockt, B.(1);Marc, F.(1);Vermeire, S.(1);Guedelha Sabino, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
N18: Mood disorders in a IBD population: a single-centre cohort
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Lorenzon*1, A. Dessì1, C. Marinelli1, A. Rigo1, S. Facchin1, M. Inferrera1, R. D'Incà1, B. Barberio1, E. V. Savarino1, F. Zingone1

Created: Friday, 22 February 2019, 9:41 AM
N18: Multidisciplinary team importance in the view of the patients with Inflammatory Bowel Disease in Brazil
Year: 2021
Source: ECCO'21 Virtual
Authors: Herrerias, G.(1);Ribeiro, J.R.(1);Beraldo, R.F.(1);Hossne, R.S.(1);Baima, J.P.(1);Sassaki, L.Y.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
N19 Understanding the emotional impact of inflammatory bowel disease: looking after nurses looking after patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Younge1, L. Medcalf2, A. Hall3, C. Shaw4

Created: Thursday, 30 January 2020, 10:12 AM
N19: Fear of not being accepted: a synthesis of qualitative experiences of children and adolescents living with IBD.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Craddock, S.(1)*;Fourie, S.(1);
Created: Friday, 14 July 2023, 10:43 AM
N19: Improving the standard of care for patients with IBD - translating the N-ECCO Consensus Statements
Year: 2022
Source: ECCO'22
Authors: Kjaer-Mikkelsen, E.(1);Hindhede, A.(2);Bager, P.(3);
Created: Friday, 11 February 2022, 3:52 PM
N19: Validity of a Korean Version of inflammatory bowel disease–fatigue scale
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. H. Lee1, E. S. Kim2, H. D. Kim*3

Created: Friday, 22 February 2019, 9:41 AM
Files: 1
N20 The impact of inflammatory bowel disease-related fatigue on health-related quality of life: a qualitative semi-structured interview study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Radford1, G.W. Moran1, W. Czuber-Dochan2

Created: Thursday, 30 January 2020, 10:12 AM
N20: Experience with therapeutic drug monitoring on adalimumab in paediatric inflammatory bowel disease (pIBD)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Sider*1, L. Cococcioni1, A. ElZein1, S. Chadokufa1, R. Buckingham1, N. Shah1, A. Ocholi1, O. Borrelli1, F. Kiparissi1

Created: Friday, 22 February 2019, 9:41 AM
Files: 1
N20: Safety of extended blood monitoring for adult Inflammatory Bowel Disease (IBD) patients on oral azathioprine during the COVID-19 pandemic: a single-centre audit
Year: 2022
Source: ECCO'22
Authors: AL-HASANI, A.(1);Younge, L.(1);Chana, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
N20: The added shame of IBD: experiences of people from various ethnic backgrounds discussing sexual wellbeing in clinical settings.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fourie, S.(1)*;Czuber-Dochan, W.(2);Norton, C.(2);
Created: Friday, 14 July 2023, 10:43 AM
N21 Self-management and healthcare utilisation of 16–21 year olds with inflammatory bowel disease (IBD) attending one Irish hospital
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Forry, M. Milewska, C. Lardner, T. Lukose, N. Godwin, K. Boland, S. Patchett, A. O’Toole

Created: Thursday, 30 January 2020, 10:12 AM
N21: Patient education is (sometimes) better than cure.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Müskens, B.(1)*;
Created: Friday, 14 July 2023, 10:43 AM
N21: The interpretation of thiopurine metabolites in clinical practice: IBD nurses experience in three North West England NHS trusts
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Campbell*1, E. Nelson2, S. Kari2, J. Hocking3, T. Hickey3

Created: Friday, 22 February 2019, 9:41 AM
Files: 1